Skip to content
Clinical Trials – home

Neoclinic Concept S.R.L.

Verified siteinfo

Romania Calea Dorobantilor Nr 3, 300298 Timisoara, Romania

  • 4 trials recruiting
  • Asthma · Chronic obstructive pulmonary disease · Angina pectoris
  • Adult patients

About Specializations

Neoclinic Concept S.R.L. in Timisoara, Romania specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Angina pectoris, Heart failure with preserved ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

At Neoclinic Concept S.R.L. in Timisoara, Romania, the Cardiology department is conducting studies in cardiovascular diseases focused on stable angina pectoris. This research is designed to assess whether new approaches can better relieve angina symptoms and improve treatment effectiveness for people with chronic heart-related chest pain.

  • Stable angina pectoris
  • Cardiovascular disease treatment evaluation
  • Testing a new anti-anginal therapy

The site’s work in this area centers on confirming clinical benefit and supporting better symptom control for patients living with ongoing heart disease.

Respiratory Disease Research

Clinical trials at this site also address respiratory tract diseases, especially chronic obstructive pulmonary disease and asthma. These studies aim to improve how breathing disorders are managed by evaluating new treatments that may reduce flare-ups, improve lung function, and support day-to-day respiratory health.

  • Chronic obstructive pulmonary disease
  • Chronic obstructive pulmonary disease (COPD)
  • Reducing exacerbations and assessing treatment benefit

This research reflects a strong focus on chronic lung conditions, with attention to both symptom relief and longer-term disease control.

Asthma and Immune-Related Studies

The site is also involved in research on immune system diseases linked to eosinophilic asthma and mild to moderate asthma. These trials are exploring whether newer therapies can better control inflammation, improve breathing outcomes, and offer more effective care for patients whose asthma remains difficult to manage.

  • Mild to moderate asthma
  • Uncontrolled moderate to severe eosinophilic asthma
  • Evaluating new anti-inflammatory treatment options

Overall, the research landscape combines respiratory and immune-focused care, with studies aimed at improving treatment effectiveness for different forms of asthma and related inflammatory lung disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calea Dorobantilor Nr 3300298 TimisoaraRomania
Recruiting now
4 trials
Conditions studied
4
Partner status
Verified site

More sites in TimisoaraRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

Angina pectoris

Not yet recruiting

Study on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
  • Sponsor:Tasly Pharmaceuticals Inc.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.